Ghent, Belgium

Geert Leroux-Roels

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Innogenetics N.v.. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geert Leroux-Roels. Retrieved from https://idiyas.com/inventor/geert-leroux-roels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Geert Leroux-Roels: Inventor in Hepatitis C Research

Introduction

Geert Leroux-Roels is an inventor associated with Ghent, Belgium, and Innogenetics N.V. His patent work includes research into human T-cell epitopes of the hepatitis C virus. The provided information lists 3 patents.

Latest Patents

One listed patent, “Immunodominant Human T-Cell Epitopes of Hepatitis C Virus,” describes polypeptides of approximately 8 to 100 amino acids containing at least eight contiguous amino acids selected from the core and/or NS3 regions of the HCV polyprotein. These sequences contain an epitope capable of stimulating T cells. The supplied data lists this patent title twice, so it is presented here once.

Career Highlights

Leroux-Roels’s listed patent activity connects his work at Innogenetics N.V. with the study of immune responses to hepatitis C virus. The described invention focuses on identifying viral peptide sequences that can stimulate T cells.

Collaborations

The supplied information names Robert J. Deleys and Geert Maertens as coworkers. It does not specify their roles or the details of their collaboration with Leroux-Roels.

Conclusion

Geert Leroux-Roels’s listed patent work reflects an interest in hepatitis C virus immunology, particularly T-cell-stimulating epitopes, and is associated with Innogenetics N.V.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…